Abstract
It is appropriate to start this article by looking back briefly at the recent development of our knowledge of hepatitis viruses, of hepatitis as a disease, and of its natural history because this process is the background to the specific immune prophylaxis of hepatitis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Blumberg, B.S., Gerstley, B.J.S., Hungerford, D.A., London, W.T., Sutnick, A.I.: A serum antigen (Australia antigen) in Down’s Syndrome, leukemia and hepatitis. Ann. Int. Med. 66: 924, 1967.
Crosnier, J., Jungers, P., Couroucé, A.M., Laplanche, A., Benhamou, E., Degos, F., Lacour, B., Prunet, P., Cerisier, Y., Guesry, P.: Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in French haemodialysis units: I. Medical staff. Lancet 1: 455, 1981.
Crosnier, J., Jungers, P., Couroucé, A.M., Laplanche, A., Benhamou, E., Degos, F., Lacour, B., Prunet, P., Cerisier, Y., Guesry, P.: Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in French haemodialysis units: II. Haemodialysis patients. Lancet 2: 797, 1981.
Deinhardt, F.: Immune prophylaxis of viral hepatitis. Behring Institute Mitteilungen 69: 36, 1981.
Deinhardt, F.: Serum markers of hepatitis in natural disease and after vaccination. In: Progress in Liver Disease, volume VII. Editors: H. Popper and F. Schaffner. Grune and Stratton, New York, in press.
Deinhardt, F., Zachoval, R., Schmidt, M., Frösner, H., Frösner, G. G.: Active and passive-active immunization against hepatitis virus infection. In: Hepatitis B Vaccine. Editors: P. Maupas and P. Guesl Elsevier, Amsterdam, 1981, p. 167.
Dienstag, J.L.: The pathobiology of hepatitis A virus. International Rev. Exp. Pathol. 20: 1, 1979.
Dreesman, G.R., Sanchez, Y., Ionescu-Matiu, I., Sparrow, J.T., Six, H.R., Peterson, D.L., Hollinger, F.B., Meinick, J.L.: Antibody to hepatitis B surface antigen after a single inoculation of uncoupled synthetic HBsAg peptides. Nature 295: 158, 1982.
Gauss-Müller, V., Frösner, G.G., Deinhardt, F.: Propagation of hepatitis A virus in human fibroblasts. J. Virol. Meth. 7: 233, 1981.
Gerety, R.J.(editor): Non-A, Non-B Hepatitis. Academic Press, New York, 1981, p. 1–301.
Hilleman, M.R., Buynak, E.B., McAleer, J., MacLean, A.A., Provost, P.J., Tytell, A.A.: Newer developments with human hepatitis vaccines. In: Perspectives in Virology IX. Editor: M. Pollard. Allan R. Liss, New York, 1981, p. 219.
Hollinger, F.B., Adam, E., Heiberg, D., Melnick, J.L.: Response to hepatitis B vaccine in a young adult population. In: Viral Hepatitis: 1981 International Symposium. Editors: W. Szmuness, J.W. Maynard and H.J. Alter. The Franklin Institute Press, Philadelphia, PA, 1982, p. 451.
Krugman, S., Giles, J.P., Hammond, J.: Hepatitis virus: effect of heat on the infectivity and antigenicity of the MS-1 and MS-2 strains. J. Infect. Dis. 122: 432, 1970.
Krugman, S., Giles, J.P., Hammond, J.: Viral hepatitis, type B (MS-2 strain): studies on active immunization. J. Amer. Med. Ass. 217: 41, 1971.
Lerner, R.A., Green, N., Alexander, H., Liu, F.-T., Sutcliffe, J. G., Shinnick, T.M.: Chemically synthesized peptides predicted from the nucleotide sequence of the hepatitis B virus genome elicit antibodies reactive with the native envelope protein of Dane particles. Proceedings of the National Academy of Sciences, USA 78: 3403, 1981.
Maupas, P., Barin, F., Chiron, J.P., Coursaget, P., Goudeau, A., Perrin, F., Denis, F., Diop, Mar. I.: Efficacy of hepatitis B vaccine in prevention of early HBsAg carrier state in children. Controlled trial in an endemic area (Senegal). Lancet 1: 289, 1981.
Maupas, P., Guesry, P. (editors): Hepatitis B Vaccine (INSERM symposium 18). Elsevier, Amsterdam, 1981, p. 1–318.
McAuliffe, V.J., Purcell, R.H., Gerin, J.L.: Type B hepatitis: a review of current prospects for a safe and effective vaccine. Rev. Infect. Dis. 2: 470, 1980.
Prince, A.M., Fuji, H., Gershon, R.K.: Immunohistochemical studies on the etiology of anicteric hepatitis in Korea. Amer. J. Hyg. 79: 365, 1964.
Siegl, G., Frösner, G.G., Gauss-Müller, V., Tratschin, J.D., Deinhardt, F.: The physicochemical properties of infectious hepatitis A virions. J. Gen. Virol. 57: 331, 1981.
Stevens, C.E., Szmuness, W., Goodman, A.I., Weseley, S.A., Fotino, M.: Hepatitis B vaccine: immune responses in haemodialysis patients. Lancet 2: 1211, 1980.
Szmuness, W., Oleszko, W.R., Stevens, C.E., Goodman, A.: Passive-active immunization against hepatitis B: immunogenicity studies in adult Americans. Lancet 1: 575, 1981.
Szmuness, W., Stevens, C.E., Zang, E.A., Harley, E.J., Kellner, A.: A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report. Hepatology 1: 377, 1981.
Tiollais, P., Charnay, P., Vyas, G.N.: Biology of hepatitis B virus. Science 213: 406, 1981.
Von der Helm, K., Winnacker, E.L., Deinhardt, F., Frösner, G.G., Gauss-Müller, V., Bayerl, B., Scheid, R., Siegl, G.: Cloning of hepatitis A virus genome. J. Virol. Meth. 3: 37, 1981.
Zachoval, R., Frösner, G.G., Deinhardt, F.: Impfung gegen Hepatitis B. Munch. Med. Wschr. 40: 1506, 1981.
Zuckerman, A.J.: Hepatitis B: its prevention by vaccine. J. Infect. Dis. 143: 301, 1981.
Zuckerman, A.J., Howard, C.: Hepatitis viruses in man. Academic Press, New York, 1979, p. 1–269.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 Martinus Nijhoff Publishers, The Hague
About this chapter
Cite this chapter
Deinhardt, F. (1982). Hepatitis B Virus Vaccine. In: Smit Sibinga, C.T., Das, P.C., van Loghem, J.J. (eds) Bloodtransfusion and Problems of Bleeding. Developments in Hematology and Immunology, vol 5. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-7692-4_29
Download citation
DOI: https://doi.org/10.1007/978-94-009-7692-4_29
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-009-7694-8
Online ISBN: 978-94-009-7692-4
eBook Packages: Springer Book Archive